2m 2m 2m 2m 2m 2m 2m
Metagenomi Thera (MGX)
NASDAQ
$1.22+$0.03 (+2.18%)
Price as of Aug 03, 2026 2:58 PM EDT- $44.8MMarket Cap
- -47.11%1-Year Change
- BiotechnologyIndustry
Metagenomi Thera (MGX)
$1.22+$0.03 (+2.18%)
MGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.19 | ||
Change | -$0.03 (-2.46%) | ||
Open | $1.21 | ||
High | $1.22 | ||
Low | $1.19 | ||
Previous Close | $1.22 | ||
Volume | 135,772 | ||
30-Day Average Volume | 189,427 | ||
1-Week Change | -1.24% | ||
1-Month Change | 0.00% | ||
1-Year Change | -47.11% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.6M | ||
Total Assets | $197.0M | ||
Market Cap | $44.8M | ||
Enterprise Value | $19.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$23.1M | ||
Free Cash Flow | -$21.2M | ||
EBIT | -$23.0M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $122.1M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | 1 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue